Rigel Pharmaceuticals, Inc.RIGLNASDAQ
Loading
ROE: Returns DecliningContracting
Percentile Rank86
3Y CAGR-39.8%
Studio
Year-over-Year Change

Return on equity

3Y CAGR
-39.8%/yr
Annual compound
Percentile
P86
Within normal range
vs 3Y Ago
0.2x
Contraction
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
202593.75%-82.4%
2024531.78%+507.1%
202387.60%-79.6%
2022430.18%+829.4%
2021-58.98%+32.5%
2020-87.42%+29.3%
2019-123.66%-92.8%
2018-64.14%+17.2%
2017-77.49%+38.4%
2016-125.79%-